NSE - Delayed Quote INR

Alpa Laboratories Limited (ALPA.NS)

Compare
111.56 +0.74 (+0.67%)
At close: 3:29 PM GMT+5:30
Loading Chart for ALPA.NS
DELL
  • Previous Close 110.82
  • Open 111.00
  • Bid --
  • Ask --
  • Day's Range 110.51 - 111.99
  • 52 Week Range 69.90 - 144.50
  • Volume 10,983
  • Avg. Volume 306,190
  • Market Cap (intraday) 2.371B
  • Beta (5Y Monthly) 1.04
  • PE Ratio (TTM) 11.27
  • EPS (TTM) 9.90
  • Earnings Date Feb 11, 2025 - Feb 15, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Alpa Laboratories Limited engages in the manufacture and sale of pharmaceutical finished dosage forms in India. The company offers ethical, generic, and over the counter pharmaceutical products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, creams, gels, and ointments for human and veterinary use. It also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. The company sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. It also exports its products to South and Central America, Africa, and Asia, Russia, Ukraine, Kazakhstan, and internationally. The company was founded in 1967 and is based in Indore, India.

www.alpalabs.in

410

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ALPA.NS

View More

Performance Overview: ALPA.NS

Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALPA.NS
8.00%
S&P BSE SENSEX
10.47%

1-Year Return

ALPA.NS
13.95%
S&P BSE SENSEX
20.60%

3-Year Return

ALPA.NS
89.57%
S&P BSE SENSEX
39.74%

5-Year Return

ALPA.NS
606.08%
S&P BSE SENSEX
94.02%

Compare To: ALPA.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALPA.NS

View More

Valuation Measures

Annual
As of 11/28/2024
  • Market Cap

    2.36B

  • Enterprise Value

    1.27B

  • Trailing P/E

    11.19

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.42

  • Price/Book (mrq)

    1.42

  • Enterprise Value/Revenue

    1.32

  • Enterprise Value/EBITDA

    4.34

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.94%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.09B

  • Net Income Avi to Common (ttm)

    162.42M

  • Diluted EPS (ttm)

    9.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    928.54M

  • Total Debt/Equity (mrq)

    3.45%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ALPA.NS

View More

Company Insights: ALPA.NS

Research Reports: ALPA.NS

View More

People Also Watch